<DOC>
	<DOC>NCT01224873</DOC>
	<brief_summary>Breast cancer can metastasize to the bones, which leads to another treatment if bone metastases are detected. The purpose of the study is to determine, if fluoride PET/CT is superior to bone scintigraphy with technetium. On the other side, the investigators would like to see if FDG-PET/CT is a reliable alternative to dedicated bone imaging to detect bone metastases in patients with breast cancer.</brief_summary>
	<brief_title>Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>histologically proven c. mammae clinically suspicion of bone metastases age under 18 years diabetes mellitus pregnancy other known malignant disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>bone metastasis</keyword>
	<keyword>comparison of diagnostic methods</keyword>
	<keyword>bone scintigraphy</keyword>
	<keyword>fluoride PET/CT</keyword>
	<keyword>FDG-PET/CT</keyword>
</DOC>